Cargando…

Alteration in the Cerebrospinal Fluid Lipidome in Parkinson’s Disease: A Post-Mortem Pilot Study

Lipid metabolism is clearly associated to Parkinson’s disease (PD). Although lipid homeostasis has been widely studied in multiple animal and cellular models, as well as in blood derived from PD individuals, the cerebrospinal fluid (CSF) lipidomic profile in PD remains largely unexplored. In this st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fernández-Irigoyen, Joaquín, Cartas-Cejudo, Paz, Iruarrizaga-Lejarreta, Marta, Santamaría, Enrique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146703/ https://www.ncbi.nlm.nih.gov/pubmed/33946950 http://dx.doi.org/10.3390/biomedicines9050491

Ejemplares similares

Sex-divergent effects on the NAD+-dependent deacetylase sirtuin signaling across the olfactory–entorhinal–amygdaloid axis in Alzheimer’s and Parkinson’s diseases
por: Cartas-Cejudo, Paz, et al.
Publicado: (2023)

Tackling the Biological Meaning of the Human Olfactory Bulb Dyshomeostatic Proteome across Neurological Disorders: An Integrative Bioinformatic Approach
por: Cartas-Cejudo, Paz, et al.
Publicado: (2021)

Olfactory Bulb Proteomics Reveals Widespread Proteostatic Disturbances in Mixed Dementia and Guides for Potential Serum Biomarkers to Discriminate Alzheimer Disease and Mixed Dementia Phenotypes
por: Lachén-Montes, Mercedes, et al.
Publicado: (2021)

Dysregulated Brain Protein Phosphorylation Linked to Increased Human Tau Expression in the hTau Transgenic Mouse Model
por: Ferrer, Isidro, et al.
Publicado: (2022)

Lipidomics Reveals Cerebrospinal-Fluid Signatures of ALS
por: Blasco, H., et al.
Publicado: (2017)

Predictive Modeling of Alzheimer’s and Parkinson’s Disease Using Metabolomic and Lipidomic Profiles from Cerebrospinal Fluid
por: Hwangbo, Nathan, et al.
Publicado: (2022)

Deregulated Transcription and Proteostasis in Adult mapt Knockout Mouse
por: Andrés-Benito, Pol, et al.
Publicado: (2023)

Improvement of cognitive function in wild-type and Alzheimer´s disease mouse models by the immunomodulatory properties of menthol inhalation or by depletion of T regulatory cells
por: Casares, Noelia, et al.
Publicado: (2023)

Changes in the Cerebrospinal Fluid and Plasma Lipidome in Patients with Rett Syndrome
por: Zandl-Lang, Martina, et al.
Publicado: (2022)

Docosahexaenoic Acid Ameliorates Contextual Fear Memory Deficits in the Tg2576 Alzheimer’s Disease Mouse Model: Cellular and Molecular Correlates
por: Badesso, Sara, et al.
Publicado: (2022)

Cerebrospinal fluid lipidomic fingerprint of obstructive sleep apnoea in Alzheimer’s disease
por: Dakterzada, Farida, et al.
Publicado: (2023)

Post-mortem ventricular cerebrospinal fluid cell-free-mtDNA in neurodegenerative disease
por: Lowes, Hannah, et al.
Publicado: (2020)

Novel genetic variants in MAPT and alterations in tau phosphorylation in amyotrophic lateral sclerosis post‐mortem motor cortex and cerebrospinal fluid
por: Petrozziello, Tiziana, et al.
Publicado: (2021)

Olfactory Characterization and Training in Older Adults: Protocol Study
por: Zambom-Ferraresi, Fabíola, et al.
Publicado: (2021)

Identification of Disease Markers in Human Cerebrospinal Fluid Using Lipidomic and Proteomic Methods
por: Fonteh, Alfred N., et al.
Publicado: (2006)

Cerebrospinal fluid levels of proenkephalin and prodynorphin are differentially altered in Huntington’s and Parkinson’s disease
por: Barschke, Peggy, et al.
Publicado: (2022)

Olfactory proteotyping: towards the enlightenment of the neurodegeneration
por: Fernández-Irigoyen, Joaquín, et al.
Publicado: (2019)

Cerebrospinal fluid lipidomic biomarker signatures of demyelination for multiple sclerosis and Guillain–Barré syndrome
por: Péter, Mária, et al.
Publicado: (2020)

Lipidomic traits of plasma and cerebrospinal fluid in amyotrophic lateral sclerosis correlate with disease progression
por: Sol, Joaquim, et al.
Publicado: (2021)

Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease
por: Gui, YaXing, et al.
Publicado: (2015)

GRP78 Level Is Altered in the Brain, but Not in Plasma or Cerebrospinal Fluid in Parkinson’s Disease Patients
por: Baek, Jean-Ha, et al.
Publicado: (2019)

Increased C-X-C Motif Chemokine Ligand 12 Levels in Cerebrospinal Fluid as a Candidate Biomarker in Sporadic Amyotrophic Lateral Sclerosis
por: Andrés-Benito, Pol, et al.
Publicado: (2020)

Metabolomic investigations in cerebrospinal fluid of Parkinson's disease
por: Willkommen, Desiree, et al.
Publicado: (2018)

Utility of rabies neutralizing antibody detection in cerebrospinal fluid and serum for ante-mortem diagnosis of human rabies
por: Damodar, Tina, et al.
Publicado: (2019)

Utility of Metabolomic Biomarkers to Identify Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients
por: Mowry, Christopher J., et al.
Publicado: (2021)

The Metabolomic Approach Reveals the Alteration in Human Serum and Cerebrospinal Fluid Composition in Parkinson’s Disease Patients
por: Plewa, Szymon, et al.
Publicado: (2021)

Natriuretic Peptides in Post-mortem Brain Tissue and Cerebrospinal Fluid of Non-demented Humans and Alzheimer’s Disease Patients
por: Mahinrad, Simin, et al.
Publicado: (2018)

Assessing the applicability of cerebrospinal fluid collected from the spinal cord for the determination of ethyl alcohol in post-mortem toxicology
por: Wachholz, Paulina, et al.
Publicado: (2022)

Cerebrospinal Fluid Lysosomal Enzymes and Alpha-Synuclein in Parkinson's Disease
por: Parnetti, Lucilla, et al.
Publicado: (2014)

Ceruloplasmin functional changes in Parkinson’s disease-cerebrospinal fluid
por: Barbariga, Marco, et al.
Publicado: (2015)

Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease
por: Hall, Sara, et al.
Publicado: (2016)

Blood and Cerebrospinal Fluid Biomarkers of Inflammation in Parkinson’s Disease
por: Zimmermann, Milan, et al.
Publicado: (2022)

Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies
por: Foulds, P.G., et al.
Publicado: (2012)

Applying mass spectrometry-based qualitative proteomics to human amygdaloid complex
por: Fernández-Irigoyen, Joaquín, et al.
Publicado: (2014)

Effect of PLA2G6 and SMPD1 Variants on the Lipid Metabolism in the Cerebrospinal Fluid of Patients with Parkinson's Disease: A Non-targeted Lipidomics Study
por: Li, Yongang, et al.
Publicado: (2023)

Cerebrospinal Fluid Space Alterations in Melancholic Depression
por: Via, Esther, et al.
Publicado: (2012)

Alterations in Cerebrospinal Fluid in Patients with Bipolar Syndromes
por: Endres, Dominique, et al.
Publicado: (2016)

Tau protein as a possible marker of cerebrospinal fluid leakage in cerebrospinal fluid rhinorrhoea: A pilot study
por: Oudart, Jean-Baptiste, et al.
Publicado: (2017)

Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease
por: Schröder, Jens B., et al.
Publicado: (2018)

Cerebrospinal fluid proteomics implicates the granin family in Parkinson’s disease
por: Rotunno, Melissa S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gesos11atmt0vqpa01it1cjjeo